Industry Insights on Vaccines (Technical Insights)

Strategic Portfolio Management, Trends and Prospects for Vaccines

Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

Vaccine technologies have garnered increased interest from pharmaceutical companies and biotech companies in the last few years. Not only are there companies working on newer vaccine types, but also on platform technologies for delivery, production, adjuvants and so on. This study is aimed at delivering an overview of the research portfolio for vaccines across different core segments and geographies. There is a marked difference in immunization programs and vaccine R&D across geographies, depending on country specific programs and funding, and the report delves into these aspects and discuses regional portfolio and regional business challenges.

Table of Contents

Industry Insights on Vaccines (Technical Insights), Industry Insights--Vaccines Industry Insights on Vaccines--Strategic Portfolio Management Industry Insights on Vaccines

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.